OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
March 09, 2023
In an effort to strengthen supply chain, unnamed pharma company to use chain of custody application to combat an illegal global market worth up to $200 billion annually.
New site is expected to complement CDMO’s commercial production experience.
March 08, 2023
Acquisition expands company’s eCTD submission capabilities.
March 07, 2023
Latest investigation signals more scrutiny of pharmacy benefit managers and their role in treatment cost and coverage.
The deal—potentially totaling upwards of $100 million—strengthens the company’s selection of US generic prescription products.
Stats point to a 14.9% decline compared to January of last year.
March 06, 2023
Factors to keep in mind before obtaining material in the cell therapy space.
Initiative intends to facilitate regulatory compliance within the pharma distribution space.
March 03, 2023
With the help of traceability, new feature prioritizes efficiency and safety, from production to patient.
March 02, 2023
Hoping to accelerate the drug delivery process, production is expected to begin as early as 2025.